explore -WSS

explore

author：Wikipedia 2025-08-12 09:08:18 - browse：1781

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Choosing scientific sides in the fight against Alzheimer's

WSS

Travel bans should be based on evidence, not politics or fear

Sanofi seeks simpler, safer CRISPR sickle cell cure

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

How Medicaid coverage policies for immigrants impact new moms

FDA approves RSV monoclonal antibody for infants, toddlers

knowledge

explore

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Biden praises World Series champion Astros for impact off the field during White House celebration

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

An Ebola outbreak presents a new mystery involving children

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

AI can’t replace a physician’s gut feeling

Affirmative action in medical school literally saved lives

Cosmetics set for new safety regulation. Why the industry is on board

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WHO calls for emergency meeting on new China virus, as cases spread

leisure time

In venture capital firm's success, lessons for turning crisis into profit

In early work, researchers turn to CRISPR to treat Alzheimer's

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

CDC launches VaccineFinder tool to locate Covid

Wikipedia

leisure time

focus

explore